InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
2
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+14.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by ANDREWS RONALD ASBURY, Director. Director active across 3 companies, notably Precipio, Inc.. Aggregated, 17 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €96k. Activity tracked since 1 July 2021. The latest transaction was disclosed on 15 October 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations17 total
922 sharesCommon StockSEC:0001193125-26-292654:0
568 shares@ US$17.5850.0% of flowCommon StockSEC:0001104659-26-005081
568 shares@ US$17.580.018% mcap50.0% of flowCommon StockSEC:0001104659-26-005081:0
1,785 shares@ US$5.6012.0% of flowCommon StockSEC:0001104659-25-036085:0
1,639 shares@ US$6.1013.1% of flowCommon StockSEC:0001104659-25-004156:0
1,510 shares@ US$6.6212.4% of flowCommon StockSEC:0001104659-24-109550:0
2,157 shares@ US$4.6312.4% of flowCommon StockSEC:0001104659-24-080213:0
3,153 shares@ US$6.6626.8% of flowCommon StockSEC:0001104659-24-048320:0
4,005 sharesCommon StockSEC:0001104659-23-111758:0
6,060 sharesCommon StockSEC:0001104659-23-100810:0
250,000 shares0Common Stock, no par valueSEC:0001493152-22-035089:0
40,000 shares@ US$0.9639.2% of flowCommon Stock, no par valueSEC:0001493152-22-023462:0
Ideal exit: 13 May 2023 (T+270)
50,000 shares@ US$1.283100.0% of flowCommon Stock, no par valueSEC:0001493152-22-007205:0
Ideal exit: 11 Dec 2022 (T+270)
65,000 shares0Common Stock, no par valueSEC:0001493152-21-016130:0
65,000 shares0Common Stock, no par valueSEC:0001493152-21-016130
106,221 shares0Common Stock, no par valueSEC:0001493152-21-015984
106,221 shares0Common Stock, no par valueSEC:0001493152-21-015984:0
17 of 17 declarations
About ANDREWS RONALD ASBURY
Ronald Asbury Andrews serves as Chief Executive Officer and Director at Precipio, Inc. and OncoCyte Corp. He leads the strategic operations of both companies, focusing on growth and innovation. Ronald has extensive experience in the sector, enabling him to effectively guide teams toward achieving organizational goals. His leadership is essential for the future development of the companies.
